The Impact of Donor Specific Antibodies on Survival in Lung Transplantation

被引：0
|
作者：
Morrell, M. R. [1 ]
Gries, C. J. [1 ]
Pilewski, J. M. [1 ]
Zeevi, A. [2 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
960
引用
收藏
页码：308 / 308
页数：1
相关论文
共 50 条
  • [31] Early Clearance of De Novo Donor Specific Antibodies in Lung Transplantation.
    Islam, A.
    Sinha, N.
    Jyothula, S.
    DeVos, J.
    Teeter, L.
    Graviss, E.
    Moore, L.
    Land, G.
    Knight, R.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 195 - 195
  • [32] PULMONARY THROMBOEMBOLIC DISEASE IS ASSOCIATED WITH DONOR SPECIFIC ANTIBODIES AFTER LUNG TRANSPLANTATION
    Allen, H. W. Ainge
    Havryk, A. P.
    Malouf, M. A.
    Plit, M.
    Glanville, A. R.
    RESPIROLOGY, 2012, 17 : 35 - 35
  • [33] Transient versus Persistent Donor Specific Antibodies and Outcomes After Lung Transplantation
    Auner, S.
    Hillebrand, C.
    Boehm, P. M.
    Boecker, J.
    Koren, D.
    Schwarz, S.
    Kovacs, Z.
    Murakoezy, G.
    Hielle-Wittmann, E.
    Fischer, G.
    Aigner, C.
    Hoetzenecker, K.
    Jaksch, P.
    Benazzo, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S33 - S34
  • [34] Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Emonds, Marie-Paul
    Van Raemdonck, Dirk E.
    Neyrinck, Arne P.
    Verleden, Geert M.
    Vos, Robin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (05)
  • [35] Early Clearance of De Novo Donor Specific Antibodies in Lung Transplantation.
    Islam, A.
    Sinha, N.
    Jyothula, S.
    DeVos, J.
    Teeter, L.
    Graviss, E.
    Moore, L.
    Land, G.
    Knight, R.
    Gaber, A.
    Walter, J. C., Jr.
    TRANSPLANTATION, 2014, 98 : 195 - 195
  • [36] Complement-Fixing Donor-Specific Antibodies After Lung Transplantation
    Iuppa, J. A.
    Bain, K. B.
    Phelan, D. L.
    Yusen, R. D.
    Byers, D. E.
    Witt, C. A.
    Trulock, E. P.
    Patterson, G. A.
    Mohanakumar, T.
    Hachem, R. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S184 - S184
  • [37] Outcomes of IVIG Monotherapy for Donor-Specific Antibodies After Lung Transplantation
    Spence, K.
    Heeney, S.
    Morrison, M.
    Rega, S. A.
    Irene, F. D.
    Harrison, K. B.
    Shaver, C. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 384 - 385
  • [38] DONOR SPECIFIC AND NON-DONOR SPECIFIC HLA ANTIBODIES AND LONG-TERM OUTCOME POST LUNG TRANSPLANTATION
    Verleden, Stijn
    Vanaudenaerde, Bart
    Emonds, Marie-Paul
    Van Raemdonck, Dirk
    Neyrinck, Arne
    Verleden, Geert
    Vos, Robin
    TRANSPLANT INTERNATIONAL, 2017, 30 : 164 - 164
  • [39] DONOR SPECIFIC ANTI-MHC CLASS II ANTIBODIES NEGATIVELY IMPACT ALLOGRAFT SURVIVAL FOLLOWING LIVER TRANSPLANTATION
    Iacob, S.
    Beckebaum, S.
    Lindemann, M.
    Heinemann, F. M.
    Rebmann, V.
    Wu, G.
    Schmidt, H. J.
    Kabar, I.
    Radtke, A.
    Baba, H. A.
    Cicinnati, V. R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S71 - S72
  • [40] Panel Reactive Antibodies (PRA) and Donor-Specific Antibodies (DSA) in Lung Transplantation: An Indian Experience
    Shah, U.
    Rahulan, V.
    Kamath, A.
    Kumar, S.
    Kumar, P.
    Dutta, P.
    Attawar, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S336 - S336
12345